Sectors
AGMB
AgomAb Therapeutics NV
13.01
2 x 10.01
1 x 13.10
bid
ask
-
0.16
1.21%
02:02 PM
timesize
| Ytd | -11.19% | |
| 1y | -11.19% |
12.75
day range
14.13
8.75
52 week range
17.82
| Open | 13.15 | Prev Close | 13.17 | Low | 12.75 | High | 14.13 | Mkt Cap | 640.72M |
| Vol | 57.51K | Avg Vol | 110.80K | EPS | -1.58 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 13.17 | 200-d Avg | 12.59 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 48.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 221.59M | ||
| Cash and Equivalents (USD) | 251.80M | ||
| Investments | 30.40M | ||
| Investments Current | 30.39M | ||
| Investments Non-Current | 13.00K | ||
| Current Assets | 258.48M | ||
| Property, Plant & Equipment Net | 1.41M | ||
| Total Assets | 290.92M | ||
| Debt Current | 229.00K | ||
| Total Debt | 1.14M | ||
| Current Liabilities | 20.07M | ||
| Debt Non-Current | 910.00K | ||
| Total Liabilities | 25.55M | ||
| Accumulated Retained Earnings (Deficit) | -212.62M | ||
| Shareholders Equity | 265.38M | ||
| Shareholders Equity (USD) | 301.56M | ||
| Assets Non-Current | 32.44M | ||
| Total Debt (USD) | 1.29M | ||
| Deferred Revenue | 2.39M | ||
| Goodwill and Intangible Assets | 28.72M | ||
| Liabilities Non-Current | 5.48M | ||
| Trade and Non-Trade Payables | 11.84M | ||